Last updated: July 29, 2025
Sponsor: Jehan George Sadek
Overall Status: Active - Recruiting
Phase
4
Condition
Labor/delivery
Treatment
fentanyl
Saline 0.9%
Dexmedetomidine
Clinical Study ID
NCT06823349
Asw.Uni. / 926 / 5 / 24
Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
ASA I-II.
Uncomplicated pregnancy.
At term & singleton fetus.
Cervical dilatation > 5cm
Cephalic presentations
Exclusion
Exclusion Criteria:
Patient refusal.
Bleeding disorders and patients on anticoagulant drugs.
Infection at site of injection.
Spine deformity.
Allergy to any of study medications.
Study Design
Total Participants: 90
Treatment Group(s): 3
Primary Treatment: fentanyl
Phase: 4
Study Start date:
February 01, 2025
Estimated Completion Date:
July 31, 2025
Study Description
Connect with a study center
Aswan University Hospital
Aswan,
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.